遗传性胶质瘤风险的性别特异性基因与通路建模
研究利用胶质瘤国际病例对照研究作为测试集,3项全基因组关联研究荟萃分析作为验证集,采用3种算法生成基因评分、Pascal生成通路评分,分析常染色体与X染色体名义显著SNP。男性25个基因(5个区域)、女性19个基因(6个区域)在至少2种算法中达统计学显著;EGFR仅在男性中与全部胶质瘤和胶质母细胞瘤显著相关,TERT为女性特异性关联。
要点
- 男性25个基因(5区域)、女性19个基因(6区域)在至少2种算法中显著。
- EGFR仅在男性中与全部胶质瘤和胶质母细胞瘤显著相关。
- TERT显示女性特异性关联,条件化已知风险位点后仍名义显著。
核心结论
- 结果提供额外证据表明胶质瘤遗传风险可能存在性别差异。
- 进一步分析可能阐明该风险所涉及的生物学过程。
研究设计与样本
- 以胶质瘤国际病例对照研究结果为测试集,3项全基因组关联研究经荟萃分析合并为验证集。
- 使用既往荟萃分析中名义显著常染色体SNP(P < 0.01)和名义显著X染色体SNP(P < 0.01)的汇总统计量。
- 采用Pascal、BimBam和GATES 3种算法生成基因评分,Pascal生成通路评分。
- 发现集以P < 3.3 × 10-6为统计学显著,验证集以3种算法中2种达到P < 0.001为显著。
主要发现
- 男性有25个基因位于5个区域、女性有19个基因位于6个区域在至少3种算法中的2种达到统计学显著。
- EGFR仅在男性中与全部胶质瘤和胶质母细胞瘤显著相关,条件化已知风险位点后仍名义显著。
- TERT显示女性特异性关联,条件化已知风险位点后仍名义显著。
- 男性和女性均与BioCarta端粒通路存在名义关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To date, genome-wide association studies (GWAS) have identified 25 risk variants for glioma, explaining 30% of heritable risk. Most histologies occur with significantly higher incidence in males, and this difference is not explained by currently known risk factors. A previous GWAS identified sex-specific glioma risk variants, and this analysis aims to further elucidate risk variation by sex using gene- and pathway-based approaches. METHODS: Results from the Glioma International Case-Control Study were used as a testing set, and results from 3 GWAS were combined via meta-analysis and used as a validation set. Using summary statistics for nominally significant autosomal SNPs (P < 0.01 in a previous meta-analysis) and nominally significant X-chromosome SNPs (P < 0.01), 3 algorithms (Pascal, BimBam, and GATES) were used to generate gene scores, and Pascal was used to generate pathway scores. Results were considered statistically significant in the discovery set when P < 3.3 × 10-6 and in the validation set when P < 0.001 in 2 of 3 algorithms. RESULTS: Twenty-five genes within 5 regions and 19 genes within 6 regions reached statistical significance in at least 2 of 3 algorithms in males and females, respectively. EGFR was significantly associated with all glioma and glioblastoma in males only and a female-specific association in TERT, all of which remained nominally significant after conditioning on known risk loci. There were nominal associations with the BioCarta telomeres pathway in both males and females. CONCLUSIONS: These results provide additional evidence that there may be differences by sex in genetic risk for glioma. Additional analyses may further elucidate the biological processes through which this risk is conferred.
引用
- Ostrom QT, Coleman W, Huang W, et al. Sex-specific gene and pathway modeling of inherited glioma risk. Neuro Oncol. 2019. PMID: 30124908. doi:10.1093/neuonc/noy135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。